{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T21:57:01Z","timestamp":1769551021728,"version":"3.49.0"},"reference-count":16,"publisher":"FapUNIFESP (SciELO)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Cir. Bras."],"DOI":"10.1590\/s0102-865020170120000002","type":"journal-article","created":{"date-parts":[[2018,1,10]],"date-time":"2018-01-10T07:17:33Z","timestamp":1515568653000},"page":"1006-1012","source":"Crossref","is-referenced-by-count":5,"title":["Effects of nivolumab in peritoneal carcinamatosis of malign melanoma in mouse model"],"prefix":"10.1590","volume":"32","author":[{"given":"Ozgul","family":"Duzgun","sequence":"first","affiliation":[{"name":"Umraniye Training and Research Hospital,  Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inanc Samil","family":"Sarici","sequence":"additional","affiliation":[{"name":"Kanuni Sultan Suleyman Training and Research Hospital,  Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serkan","family":"Gokcay","sequence":"additional","affiliation":[{"name":"Cukurova University,  Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kivilcim Eren","family":"Ates","sequence":"additional","affiliation":[{"name":"Cukurova University,  Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet Bertan","family":"Y\u0131lmaz","sequence":"additional","affiliation":[{"name":"Cukurova University,  Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2017,12]]},"reference":[{"issue":"4","key":"ref1","doi-asserted-by":"crossref","first-page":"356","DOI":"10.4065\/72.4.356","article-title":"Malignant melanoma prognostic indicators","volume":"72","author":"Ahmed I","year":"1997","journal-title":"Mayo Clin Proc"},{"issue":"22","key":"ref2","doi-asserted-by":"crossref","first-page":"3782","DOI":"10.1200\/JCO.2000.18.22.3782","article-title":"Prognostic factors in metastatic melanoma a pooled analysis of Eastern Cooperative Oncology Group trials","volume":"18","author":"Manola J","year":"2000","journal-title":"J Clin Oncol"},{"issue":"6","key":"ref3","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1002\/1097-0142(20010315)91:6<1148::AID-CNCR1111>3.0.CO;2-#","article-title":"Gender and other survival predictors in patients with metastatic melanoma on Southwest Oncology Group trials","volume":"91","author":"Unger JM","year":"2001","journal-title":"Cancer"},{"issue":"4","key":"ref4","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1056\/NEJMoa1412082","article-title":"Nivolumab in previously untreated melanoma without BRAF mutation","volume":"372","author":"Robert C","year":"2015","journal-title":"N Engl J Med"},{"issue":"4","key":"ref5","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S1470-2045(15)70076-8","article-title":"Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037) a randomised, controlled, open-label, phase 3 trial","volume":"16","author":"Weber JS","year":"2015","journal-title":"Lancet Oncol"},{"issue":"1","key":"ref6","first-page":"65","article-title":"Peritoneal sampling and histological assessmentof therapeutic response in peritoneal metastasis proposal of the Peritoneal Regression Grading Score (PRGS)","volume":"2","author":"Solass W","year":"2016","journal-title":"Pleura Peritoneum"},{"issue":"2","key":"ref7","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1067\/S0190-9622(03)00421-3","article-title":"Primary jejunal malignant melanoma first noticed because of the presence of parotid lymph node metastasis","volume":"49","author":"Iijima S","year":"2003","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"ref8","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/GOX.0000000000000122","article-title":"Long-term survival after metastatic childhood melanoma","volume":"2","author":"Larsen AK","year":"2014","journal-title":"Plast Reconstr Surg Glob Open"},{"issue":"8","key":"ref9","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi FS","year":"2010","journal-title":"N Engl J Med"},{"issue":"6","key":"ref10","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1200\/JCO.2004.04.165","article-title":"Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma","volume":"22","author":"Avril MF","year":"2004","journal-title":"J Clin Oncol"},{"issue":"3","key":"ref11","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.hoc.2009.03.006","article-title":"The history and future of chemotherapy for melanoma","volume":"23","author":"Yang AS","year":"2009","journal-title":"Hematol Oncol Clin North Am"},{"issue":"12","key":"ref12","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.ejca.2004.04.030","article-title":"Re-evaluating the role of dacarbazine in metastatic melanoma what have we learned in 30 years?","volume":"40","author":"Eggermont AM","year":"2004","journal-title":"Eur J Cancer"},{"issue":"2","key":"ref13","first-page":"132","article-title":"Advances in immunotherapy for metastatic melanoma","volume":"61","author":"Ol\u00e1h J","year":"2017","journal-title":"Magy Onkol"},{"issue":"10","key":"ref14","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1200\/JCO.2013.53.0105","article-title":"Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab","volume":"32","author":"Topalian SL","year":"2014","journal-title":"J Clin Oncol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3389\/fonc.2013.00262","article-title":"Tumor regression grading of gastrointestinal carcinomas after neoadjuvant treatment","volume":"3","author":"Thies S","year":"2013","journal-title":"Front Oncol"},{"key":"ref16","article-title":"Neoadjuvant chemoradiotherapy for rectal cancer: how important is tumour regression","author":"McCoy MJ","year":"2015","journal-title":"ANZ J Surg"}],"container-title":["Acta Cirurgica Brasileira"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/acb\/v32n12\/1678-2674-acb-32-12-01006.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T18:44:33Z","timestamp":1603133073000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0102-86502017001201006&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":16,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["S0102-86502017001201006"],"URL":"https:\/\/doi.org\/10.1590\/s0102-865020170120000002","relation":{},"ISSN":["1678-2674","0102-8650"],"issn-type":[{"value":"1678-2674","type":"electronic"},{"value":"0102-8650","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]}}}